Invention Application
- Patent Title: HETEROCYCLIC COMPOUND
- Patent Title (中): 杂环化合物
-
Application No.: US14779347Application Date: 2014-03-27
-
Publication No.: US20160039811A1Publication Date: 2016-02-11
- Inventor: Masato YOSHIDA , Hiroyuki NAGAMIYA , Yusuke OHBA , Masaki SETO , Takatoshi YOGO , Satoshi SASAKI , Norihito TOKUNAGA , Kazuyoshi ASO
- Applicant: TAKEDA PHARMACETICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Priority: JP2013-070477 20130328
- International Application: PCT/JP2014/058999 WO 20140327
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00

Abstract:
Provided is a compound or a salt thereof, which has an excellent JAK inhibitory action, and is useful as a prophylactic or therapeutic agent for autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's syndrome, multiple sclerosis, systemic lupus erythematosus, etc.), cancer (leukemia, uterine leiomyosarcoma, prostate cancer, multiple myeloma, cachexia, myelofibrosis, etc.) and the like. The present invention relates to a compound represented by the formula (I) wherein each symbol is as defined in the present specification, or a salt thereof.
Public/Granted literature
- US09637483B2 Heterocyclic compound Public/Granted day:2017-05-02
Information query